A clinical trial to evaluate the experimental Ebola treatment ZMapp found it to be safe and well-tolerated; however, because of the waning Ebola epidemic, the study enrolled too few people to determine definitively whether it is a better treatment for Ebola virus disease (EVD) than the best available standard of care alone. The findings from the randomized, controlled trial known as PREVAIL II appear in the Oct. 13, 2016 issue of The New England Journal of Medicine. Initial trial findings were reported in February 2016, at the Conference on Retroviruses and Opportunistic Infections in Boston.

Related posts:

  1. NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute […]...
  2. Funded study finds more precise way to estimate kidney function Measuring creatinine and cystatin C — two markers for chronic kidney disease (CKD) — more precisely estimates kidney function than either marker alone, according to a study funded by the National Institutes of Health. Results appear in the July 5 issue of the New England Journal of Medicine....
  3. Medicare Card, NIH-funded study supports surgery as treatment for myasthenia gravis Medicare Card, NIH-funded study supports surgery as treatment for myasthenia gravis...
  4. Medicare, Medicare Card, Study Finds Two Sling Surgeries, Equally Effective for Bladder Control in Women Two common operations for stress urinary incontinence (SUI) help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine […]...
  5. Adverse Cardiovascular Events Reported in Testosterone Trial in Older Men A clinical trial of testosterone treatment in older men, reported June 30 online in the New England Journal of Medicine, has found a higher rate of adverse cardiovascular events, such as heart attacks and elevated blood pressure, in a group of older men receiving testosterone gel compared to those receiving placebo. Due to these events, […]...
  6. Medicare Card, Study shows promise of precision medicine for most common type of lymphoma Medicare Card, Study shows promise of precision medicine for most common type of lymphoma...
  7. Medicare Card, Adding chemotherapy following radiation treatment improves survival for adults with a slow-growing type of brain tumor Medicare Card, Adding chemotherapy following radiation treatment improves survival for adults with a slow-growing type of brain tumor...
  8. Medicare Card, NIH mouse study finds gut microorganisms may determine cancer treatment outcome An unhealthy gut microbiome may limit treatment effectiveness.  An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, and their […]...
  9. Study finds sigmoidoscopy reduces colorectal cancer rates Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths due to colorectal cancer, according to research sponsored by the National Cancer Institute, part of the National Institutes of Health. In a study that spanned […]...
  10. Medicare Card, NIH-developed candidate dengue vaccine shows promise in early-stage trial Medicare Card, NIH-developed candidate dengue vaccine shows promise in early-stage trial...
  11. Funded study shows reduction in death for men with intermediate-grade prostate cancer Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly […]...
  12. Medicare Card, Landmark NIH blood pressure study confirm that lower blood pressure target can reduce cardiovascular disease, deaths Medicare Card, Landmark NIH blood pressure study confirm that lower blood pressure target can reduce cardiovascular disease, deaths ...
  13. Medicare Card, Common treatment for patients with chronic, progressive lung disease found to be ineffective Medicare Card, Common treatment for patients with chronic, progressive lung disease found to be ineffective...
  14. Medicare Card, Paramedics may be first line of treatment for stroke Medicare Card, Paramedics may be first line of treatment for stroke...
  15. Medicare Card, Sepsis study comparing three treatment methods shows same survival rate Medicare Card, Sepsis study comparing three treatment methods shows same survival rate...